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Abstract
Background: To evaluate in patients with aggressive periodontitis (AgP) the effect of nonsurgical periodontal
treatment in conjunction with either additional administration of systemic antibiotics (AB) or application of
photodynamic therapy (PDT) on the gingival crevicular fluid (GCF) concentration of matrix metalloproteinases 8
and 9 (MMP-8 and -9).
Methods: Thirty-six patients with AgP were included in the study. Patients were randomly assigned to treatment
with either scaling and root planing (SRP) followed by systemic administration of AB (e.g. Amoxicillin + Metronidazole)
or SRP + PDT. The analysis of MMP-8 and -9 GCF concentrations was performed at baseline and at 3 and 6 months after
treatment. Nonparametric U-Mann-Whitney test was used for comparison between groups. Changes from baseline
to 3 and 6 months were analyzed with the Friedman’s ANOVA test with Kendall’s index of consistency.
Results: In the AB group, patients showed a statistically significant (p = 0.01) decrease of MMP-8 GCF level at both
3 and 6 months post treatment. In the PDT group, the change of MMP-8 GCF level was not statistically significant.
Both groups showed at 3 and 6 months a decrease in MMP-9 levels. However, this change did not reach statistical
significance.
Conclusions: Within the limits of the present study, it may be suggested that in patients with AgP, nonsurgical
periodontal therapy in conjunction with adjunctive systemic administration of amoxicilin and metronidazole is
more effective in reducing GCF MMP-8 levels compared to the adjunctive use of PDT.
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Background
Aggressive periodontitis (AgP) is characterized by a rapid
destruction of periodontal supporting tissues leading to
pocket formation, loss of clinical attachment and alveolar
bone. When left untreated, AgP results in deterioration of
tooth prognosis, thus severely affecting long-term tooth
survival [1, 2]. The etiology of AgP is complex, consisting
of potential local host response deficiencies coupled with
infection with certain periodontopathic microorganisms
such as Aggregatibacter actinomycetemcomitans (A.a.)
and Porphyromonas gingivalis (P.g.) [3–5]. Generally,
patients with AgP show a more moderate response to
mechanical debridement alone [6, 7]. This is probably
due to the tissue invading capacity of A.a. and P.g. [3–5]
which makes their elimination by means of mechanical
therapy alone extremely difficult [6, 7]. The systemic
administration of amoxicillin and metronidazole in
conjunction with mechanical debridement (SRP) has
been shown to be a successful method to reduce or
eliminate A.a. and P.g. and to improve the clinical out-
comes [6–8]. However, the use of antibiotic therapy is
often accompanied by undesirable side effects involving
the digestive system and genitourinary tract as well as the
development of bacterial resistance [9, 10]. Furthermore,
patient compliance appears to be also an important issue
related to the use of systemic antibiotics, which in turn,
may influence the development of bacterial resistance and
the clinical outcomes [10–12].
The use of photodynamic therapy (PDT) involving the
combination of visible light (e.g. usually a diode laser)
and a photosensitizer in conjunction with SRP has been
shown to substantially reduce the bacterial load and to
result in improved clinical outcomes compared to the
use of SRP alone [13, 14]. The results of a very recent
controlled clinical study have shown that in patients with
AgP, nonsurgical periodontal therapy in conjunction with
either systemic administration of amoxicillin and metro-
nidazole or followed by 2 x topical application of aPDT
resulted in significant clinical improvements evidenced by
probing depth (PD) reduction, gain of clinical attachment
(CAL) and reduction of inflammation as evidenced by
improvements in bleeding on probing (BOP) scores at 3
and 6 months. However, treatment with amoxicillin and
metronidazole, has led to statistically significantly higher
reductions in mean PD and in the number of pockets
≥ 7 mm compared with the application of PDT [15, 16].
Gingival crevicular fluid (GCF) is an inflammatory ex-
udate, which increases significantly in inflammatory con-
ditions within periodontal tissues [17–22]. The increase
of GCF is accompanied by migration of neutrophils,
which leads subsequently to a release of matrix metallo-
proteinases 8 and 9 (MMP-8 and -9) from their granules
[17–22]. Several studies have indicated that extracellular
matrix metalloproteinases (MMPs), especially MMP-8 and
MMP-9, may play a major role in periodontal tissue
destruction [20]. Söder [23] and Leppilahti [24] observed
significantly higher levels of MMP-8 and MMP-9 in GCF
of patients with periodontal disease compared to healthy
controls. High levels of MMP-8 and MMP-9 in GCF were
found in patients with chronic and aggressive periodontitis
[25, 26]. Therefore, during the last years, it was suggested
to use the presence and concentration of certain MMPs,
e.g. MMP-8 MMP-8 or MMP-9 GCF levels to monitor
periodontal tissue conditions [21–26]. On the other hand,
the data evaluating the effect of various periodontal treat-
ment protocols on the MMP levels in the crevicular fluid
are still limited data. Moreover, to the best of our know-
ledge, at present it is unknown to what extent nonsurgical
periodontal therapy in conjunction with either additional
administration of systemic antibiotics (AB) or application
of PDT may influence MMP-8 or MMP-9 GCF levels in
patients with AgP.
Therefore, the aim of this study was to evaluate the ef-
fect of nonsurgical periodontal treatment in conjunction
with either additional administration of amoxicillin and
metronidazole or application of PDT on the concen
tration of MMP-8 and -9 in GCF.
Methods
Patients and study design
The study design, patient population, treatment protocol
together with the 3 and 6 months results have been
described previously in great detail [15, 16]. Briefly, the
study was an examiner-blind, prospective, randomised,
intra-individual comparative, single-centre clinical study.
Prior to participation, the purpose and risks of the investi-
gation were fully explained to all participants and written
informed consent was obtained from all patients. The
study protocol was approved by the ethical committee of
the Bialystok University (approval no. R-I-002/307/2009)
and conducted according to the principles outlined in the
Declaration of Helsinki on experimentation involving
human subjects in the Department of Periodontology,
Medical Academy Bialystok, Poland.
Thirty-six patients (24 females, 12 males) suffering from
aggressive periodontitis [1] with at least 3 sites with PD ≥
6 mm were recruited for the study and randomized in two
parallel groups of 18 patients each.
Following one or more appointments including thor-
ough oral hygiene instructions and supragingival scaling
and polishing, all pockets ≥ 4 mm were treated by means
of SRP using ultrasonic scalers and hand instruments.
All treatments were performed under local anaesthesia. In
the aPDTgroup, the photosensitizer (HELBO® Blue Photo-
sensitizer, Helbo Photodynamic Systems GmbH & Co KG;
Wels, Austria) was applied into the pockets from apically
to coronally. After 3 min. the pockets were rinsed with
sterile NaCl solution and subsequently irradiated with a
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diode laser tip (HELBO® minilaser 2075Fdent, Helbo
Photodynamic Systems GmbH & Co KG; wavelength
660 nm) for one minute.
In the antibiotic group (AB), the patients were prescribed
375 mg of amoxicillin and 250 mg of metronidazole 3 ×
daily for 7 days, starting on the day of SRP [7, 15, 16].
GCF sampling
GCF was obtained from the deepest periodontal pocket
per patient (≥6 mm deep), chosen at baseline. After iso-
lation of the tooth with cotton rolls, dental plaque was
gently removed and the tooth was air-dried. GCF was
collected with sterile paper strips (Periopaper, Interstate
Drug Exchange, Amityville, NY, USA), introduced into
the periodontal pocket at the depth of 1-2 mm for 30s.
The GCF volume (Sulcus Fluid Flow Rate- SFFR) absorbed
in a paper strip was measured with a calibrated device
(Periotron 8000, Oraflow, Plainview, NY). Following meas-
urement, the samples were immediately placed in Eppen-
dorf tubes containing 20 μl PBS (phosphate buffered
saline) and frozen at − 20 °C. At 3 and at 6 months GCF
was collected exactly from the same sites as at baseline.
GCF MMP-8 and MMP-9 analyses
The MMP-8 and -9 GCF concentrations were evaluated
with the ELISA method using commercially available kits
(R&D Systems, Minneapolis, MN, USA) according to the
producer’s manual.
Statistical analysis
Statistical analysis was perfomed with Statistica 10 soft-
ware (StatSoft, Tulsa OH, USA). Nonparametric U-Mann-
Whitney test was used for comparison between groups.
For the statistical evaluation of the changes from baseline
to 3 and 6 months the Friedman’s ANOVA test with
Kendall’s index of consistency was used. The results
were considered statistically significant at p < 0.05.
Results
Prior to treatment, the levels of SFFR, MMP-8 and
MMP-9 in GCF did not show statistically significant dif-
ferences between the two groups. SFFR values diminished
significantly (p = 0.006 A; p = 0.001 PDT) in both groups,
but there were no differences between the groups at 3 and
6 months (Table 1).
In the AB group, patients showed a statistically signifi-
cant (p = 0.01) decrease of MMP-8 GCF level at both 3
and 6 months post treatment. In the PDT group, a
decrease of MMP-8 GCF level was also noted, but the
change was not statistically significant.
At 3 and 6 months statistically significant differences
were found between the antibiotic and PDT groups (p =
0.04 and p = 0.01, respectively) (Table 2).
Compared to baseline, the MMP-9 levels showed, in
both groups, a decrease at 3 and 6 months. However, this
change did not reach statistical significance (Table 3).
Discussion
The results of the present study revealed that in patients
with AgP the use of amoxicillin and metronidazole re-
sulted in a statistically significant reduction of MMP-8
GCF levels at 3 and 6 months after treatment. Treatment
with SRP + PDT yielded a reduction in MMP-8 GCF level,
but this change was not statistically significant. Compared
to the application of PDT, the systemic administration of
amoxicillin and metronidazole has led at both evaluation
time points to statistically significantly higher reductions
of MMP-8 CGF levels compared to the application of
PDT. These findings are in line with the clinical results,
which have demonstrated statistically and clinically signifi-
cantly higher clinical improvements in amoxicillin plus
metronidazole group compared to the PDT one (i.e. at six
months following therapy the total number of pockets ≥
7 mm was reduced from 141 to 3 in the antibiotic group,
Table 1 Comparison of the mean values of SFFR (± standard
deviation) between groups and between examinations
Examination A PDT Group versus
group; p
I 121.15 ± 37.42 128.55 ± 38.48 0.51 NS
II 81.10 ± 50.99 91.20 ± 43.16 0.30 NS
III 89.85 ± 45.24 96.30 ± 43.10 0.61 NS
Timing; 0.006* 0.001*
A—patients with aggressive periodontitis, who underwent SRP and
antibiotic therapy
PDT-patients with aggressive periodontitis, who underwent SRP and PDT
I—baseline
II—3 months after treatment
III—6 months after treatment
NS not significant
*p < 0.05; statistically significant
Table 2 Comparison of the mean values of MMP-8 (± standard
deviation) between groups and between examinations
Examination A PDT Group versus group; p
I 42.18 ± 38.19 61.30 ± 63.43 0.62 NS
II 12.03 ± 12.08 35.81 ± 41.94 0.04*
III 13.23 ± 8.71 30.32 ± 29.77 0.01*
Timing; 0.01* 0.06 NS
A—patients with aggressive periodontitis, who underwent SRP and
antibiotic therapy
PDT-patients with aggressive periodontitis, who underwent SRP and PDT
I—baseline
II—3 months after treatment
III—6 months after treatment
NS not significant
*p < 0.05; statistically significant
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while the corresponding values were 137 and 45, respect-
ively in the PDT one) [15, 16]. Comparable findings were
also reported by Goncalves et al. [26] who found dramatic
decrease in MMP-8 and-9 levels after SRP and systemic
use of Amoxicillin +Metronidazole. Thus, the present
changes of GCF MMP-8 levels reflect the clinical
improvements and provide additional evidence for the
efficacy of amoxicillin and metronidazole in the treatment
of patients with AgP [6–8, 15, 16].
The fact that the application of PDT in conjunction
with SRP has failed to result in statistically significant
reduction of MMP-8 CGF level compared to baseline ap-
pears to indicate that in patients with AgP, the application
of PDTadditionally to SRP leads to a more moderate heal-
ing response compared to the systemic administration of
amoxicillin and metronidazole. These findings might be
explained by the capacity of certain periodontopathic
bacteria such as A.a. and P.g. to adhere to cells and to in-
vade cells even in deeper soft tissues layers surrounding
periodontally diseased teeth [3].
Since it has been demonstrated that the cytotoxic prod-
uct which results following PDT, e.g. O2, cannot migrate at
a deeper distance than 0.02 μm after its formation, it may
be anticipated that PDT is more suitable for local applica-
tion without reaching distant molecules, cells or organs
[27]. Hence, it appears that the systemic administration
of an adequate dose of specifically selected antibiotics
may have a substantially higher potential to reach the
cells harboring periodontopathic bacteria than the
application of PDT.
On the other hand, it has to be kept in mind that des-
pite the fact that the clinical improvements obtained in
the antibiotic group were significantly higher compared
to those obtained with PDT, the use of PDT has also led
to statistically significant improvements compared to
baseline [15, 16]. These results corroborate, at least in
part, very recent findings in patients with AgP evaluating
the adjunctive use of PDT to SRP. At 90 days, in deep
periodontal pockets ≥ 7 mm at baseline, the adjunctive
application of PDT yielded statistically significantly
higher decrease in PD and clinical attachment gain
compared to treatment with SRP. The SRP + PDT
group also demonstrated significantly less periodontal
pathogens of red and orange complexes and a lower ratio
IL-1β/IL-10 than the SRP Group [28]. However, when
comparing the aforementioned results to our findings, it
has to be kept in mind, that differences in the frequency
of PDT application after SRP (i.e. 2× versus 4×) may have
also influenced the outcomes. Taken together, the available
data appear to suggest a potential role of PDT in modulat-
ing periodontal inflammation [13, 14].
In the present study, the MMP-9 levels were reduced
in both groups. Despite the fact that the reduction of
MMP-9 levels was greater in the antibiotic group, the dif-
ferences between the examinations periods and among
the groups did not reach statistical significance. This find-
ing is somewhat in contradiction with those reported data
by Gocalves et al. [26] who have reported statistically
significant reductions in MMP-1, MMP-8, MMP-9,
MMP-12, and MMP-13 levels up to 6 months, comparable
to healthy sites. Significant correlations were noted between
MMP-2, MMP-3, MMP-8, MMP-9, MMP-12, and MMP-
13 levels and percentage of sites with PD >4 mm. Other
authors have also reported a reduction of multiple inflam-
matory biomarkers including MMP-9 levels after different
modalities of periodontal therapy, but the responses were
inconsistent among the subjects while the changes of
inflammatory markers correlated poorly with clinical pa-
rameters [29]. Moreover, GCF MMP-8 and MMP-9 data
showed very high standard deviations, which may be re-
lated with individual variability. Obviously, these very high
standard deviations prevented detection of statistically
significant differences between different time points and
between the study groups at the same time points.
These inconsistent findings are also in line with the
conclusions of a sytematic review which indicated that at
present, no single or combination of markers exists that
can reveal periodontal destruction adequately and further
studies are needed to provide an objective demonstration
of the use of such markers to monitor periodontal de-
struction [22].
When interpreting the present results, it should be
mentioned that from a scientific point of view a third
group of AgP patients, treated with SRP alone, would have
been of interest to evaluate and compare the additive ef-
fects of antibiotics and PDT. On the other hand, substan-
tial data from the literature has provided clear evidence
indicating that the use of systemic antibiotics represents
today’s state of the art in the treatment of AgP [6–8].
Therefore, for obvious ethical reasons, the inclusion of a
third treatment arm using SRP alone was not feasible.
Table 3 Comparison of the mean values of MMP-9 (± standard
deviation) between groups and between examinations
Examination A PDT Group versus
group; p
I 172.26 ± 106.65 352.92 ± 73.72 0.35 NS
II 68.36 ± 66.88 199.55 ± 169.39 0.13 NS
III 58.2 ± 33.05 198.42 ± 107.64 0.80 NS
Timing 0.09 NS 0.17 NS
A—patients with aggressive periodontitis, who underwent SRP and
antibiotic therapy
PDT-patients with aggressive periodontitis, who underwent SRP and PDT
I—baseline
II—3 months after treatment
III—6 months after treatment
NS not significant
*p < 0.05; statistically significant
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Conclusions
Within their limits, the present results indicate that in
patients with AgP, nonsurgical periodontal therapy in
conjunction with adjunctive systemic administration of
amoxicilin and metronidazole is more effective in redu-
cing GCF MMP-8 levels compared to the adjunctive use
of PDT.
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